In conclusion, the current research demonstrated that combined ARP with EX intervention could protect livers in response to obesity-induced metabolic disorders by upregulating the PGC-1α-mediated mitochondrial biogenesis. This evidence concerns the gene PPARGC1A and metabolic disease.